Because activated hepatic stellate cells (HSC) are the primary source of collagen in established liver fibrosis, we sought to test whether HSC-activated myofibroblast functions as the cellular target of MSC-ex for anti-LOXL2 therapies. Here, LOXL2 is linked to Hepatic fibrosis.